Patient-Derived Xenograft Models of Pancreatic Cancer

Patient-derived xenograft (PDX) models provide a predictive preclinical model for the evaluation of an agent’s efficacy prior to entering the clinic. The Crown Bioscience pancreatic collection contains over 100 models, including models of both North American and Asian descent. More

Benefits of Crown Bioscience’s Pancreatic Cancer PDX Models

Our pancreatic cancer patient-derived xenograft models offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, Patient derived xenografts reflect the heterogeneity and diversity of the human patient population. PDX will give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. Crown Bioscience’s HuPrime® Pancreatic cancer PDX model collection is well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.

MODEL NUMBERCANCER SUBTYPE # per page
PA0226AdenocarcinomaCLICK TO VIEW
PA0372ADCCLICK TO VIEW
PA0527ADCCLICK TO VIEW
PA0573NACLICK TO VIEW
PA0692ADCCLICK TO VIEW
PA0787ADCCLICK TO VIEW
PA0968ADCCLICK TO VIEW
PA1168Ductal adenocarcinomaCLICK TO VIEW
PA1170Ductal adenocarcinomaCLICK TO VIEW
PA1178Ductal adenocarcinomaCLICK TO VIEW
PA1189Ductal adenocarcinomaCLICK TO VIEW
PA1194Ductal adenocarcinomaCLICK TO VIEW
PA1198Ductal adenocarcinomaCLICK TO VIEW
PA1214ADCCLICK TO VIEW
PA1221Ductal adenocarcinomaCLICK TO VIEW
PA1222Ductal adenocarcinomaCLICK TO VIEW
PA1226Ductal adenocarcinomaCLICK TO VIEW
PA1229ADCCLICK TO VIEW
PA1233Ductal adenocarcinomaCLICK TO VIEW
PA1252Ductal adenocarcinomaCLICK TO VIEW

Create Account to View All Model Data

Already Registered? Login